Author: OurCrowd

OurCrowd’s portfolio company BioCatch featured in the Times of Israel

OurCrowd portfolio company BioCatch was featured in the Times of Israel, an English-language news website covering Israel, the region & the Jewish world. The company has developed a novel form of authentication used by online businesses to continuously guarantee users are who they say they are, by analyzing their behavioral and cognitive responses. What’s the best way to make sure that cyber-crooks don’t have the opportunity to raid bank or credit card accounts belonging to legitimate customers? By keeping them out of the system in the first place, according to Oren Kedem, VP of products at cyber-security startup BioCatch. The newest release of the Tel Aviv startup’s technology now enables banks and online financial sites to detect fraudsters during the account-opening process, so that they can be booted off the site before they have an opportunity to steal anything. BioCatch raised $3,334,500 from OurCrowd investors in February 2014. Read more on the Times of...

Read More

Israel’s Gateway to Asia: A Budding Business Relationship, a Perennial Investment Future

As a gateway to mainland China and a hub for operation in Asia, Hong Kong sits in a unique position to work with the Israeli startup and investment ecosystem. In 2012, bilateral trade between Hong Kong and Israel reached US$4.5 billion. How can Israel and Hong Kong further this blossoming partnership? The following webinar, part of the OurCrowd Teach-In Tuesdays series, explores the future of the relationship between Israel and Asia. Jonathan Sternberg, Israel Consultant at Invest Hong Kong, Victor Ofstein, COO of FreightOS, an Israeli startup operating out of Hong Kong, and Aurora Carlson, OurCrowd’s Asia Investor Relations Manager, engaged in a lively discussion on the budding Israel-Asia business ties. Topics covered in this webinar: Intro to Hong Kong’s business environment and advantages for Israeli companies looking to expand into Asia. What captivates Chinese investors about the new Silicon Valley – Israel’s startup ecosystem. How China and Israel working together could place both countries in the forefront of hi-tech success. ::::::::::::::::::::::::::::::::: To stay updated on future events and the best news from the Startup Nation, sign up for our newsletter, email us, and follow us on social...

Read More

[Pixie in Haaretz] Missing Cat Turns Into a Find-anything Startup

You’re tired of misplacing your wallet, looking for your keys and wondering where the devil the cat got to. There is the “Internet of Things,” which doesn’t help you find the animal; and now there is the “Location of Things.” Not only can Pixie help find things. It can warn you if, for example, you get up to leave a restaurant and left your wallet behind, says its founder, Amir Bassan-Eskenazi. Read more in...

Read More

OurCrowd’s portfolio company Pixie featured in Ha’aretz

OurCrowd’s portfolio company Pixie was featured in Ha’aretz, a leading English-language Website for real-time news and analysis of Israel and the Middle East. The company is both a technology platform and a consumer product with the goal of keeping the things that matter to you — and to others — in sight. Not only can Pixie help find things. It can warn you if, for example, you get up to leave a restaurant and left your wallet behind, says its founder, Amir Bassan-Eskenazi. “Pixie was founded exactly for you to find, organize and even protect objects in the real physical world,” says Bassan-Eskenazi, who also founded BigBand Networks. Pixie raised $1,547,123 from OurCrowd investors in November 2014. Read more on...

Read More

Chiasma raises $70M, Israel’s gateway to Asia, & Tel Aviv is world’s 3rd tech-friendly city [OurCrowd Newsletter]

While Israel is developing its relationship with the gateway to Asia, Tel Aviv is officially the world’s third tech-friendliest city. As always, it’s a great time to be a part of the Startup Nation. Read on. Start getting this weekly newsletter via email: Subscribe now Israel’s Chiasma raises $70M to treat growth hormone disorders Biopharmaceutical developer, Chiasma, has announced the closing of a $70 million Series E financing round. The company is developing octreotide capsules, its lead product for the orphan condition acromegaly (a disorder stemming from an excess of growth hormones). Chiasma will use the funds to prepare for the commercial launch of its treatment. The company is headquartered in Jerusalem and Newton, Massachusetts. Learn more OurCrowd in the News Nextpeer featured in VentureBeat StackIQ featured in TechRadar BillGuard featured on Startup Camel Podcast OurCrowd featured in Crowdfund Insider OurCrowd’s Jon Medved on CNN BioCatch featured in Mobile ID World Consumer Physics in The Globe and Mail Covertix featured in CRN UK 2 Israeli startups vie for MasterCard accelerator slot Two Tel Aviv-based financial technology startups, Sling and Shopnfly, will be representing Israel at a major event being held by MasterCard in Dublin...

Read More